GlassScriptPhysician profile
Jeffrey Solinas
NPI 1962498006
$6,934.07
in general payments reported to CMS, 2019-2025
35 companies · $630 in 2025
The $630 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $608 · 2020: $936 · 2021: $913 · 2022: $966 · 2023: $1,539 · 2024: $1,342 · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,510.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,391.53 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $827.01 | 2020-2025 | Evenity, Prolia, Otezla |
| Abbvie INC. | $825.81 | 2019-2025 | Vraylar, Mavyret, Qulipta |
| Pfizer INC. | $567.17 | 2021-2025 | |
| Glaxosmithkline, LLC. | $373.10 | 2019-2025 | Arexvy, Shingrix, Bexsero |
| Lilly USA, LLC | $322.95 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $283.51 | 2019-2024 | Jardiance |
| Gilead Sciences, INC. | $232.72 | 2019-2022 | |
| Philips North America LLC | $216.97 | 2023-2024 | (5050) Ext Holter, (5044) Mcot |
| Janssen Pharmaceuticals, INC | $178.75 | 2020-2021 | |
| Mylan Specialty L.P. | $171.04 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $168.98 | 2022 | |
| Alkermes, INC. | $156.22 | 2023-2024 | Vivitrol, Vivitrol |
| Viiv Healthcare Company | $148.65 | 2024-2025 | Apretude |
| Allergan, INC. | $139.32 | 2019-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $114.08 | 2023-2025 | |
| Abbott Laboratories | $105.17 | 2022-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Collegium Pharmaceutical, INC. | $86.61 | 2020 | |
| Idorsia Pharmaceuticals US INC | $80.40 | 2023 | Quviviq |
| Sanofi-Aventis U.S. LLC | $70.84 | 2020-2021 | |
| Organon LLC | $68.89 | 2022-2023 | Nexplanon |
| Seqirus USA INC | $63.42 | 2022-2025 | Flucelvax |
| Exact Sciences Corporation | $54.73 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $47.21 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.10 | 2019 | |
| Avanir Pharmaceuticals, INC. | $36.59 | 2022 | |
| Hologic Sales and Service, LLC | $25.14 | 2025 | Aptima |
| Otsuka America Pharmaceutical, INC. | $22.69 | 2024 | Rexulti |
| Dexcom, INC. | $21.06 | 2023 | Dexcom G6 Transmitter |
| Fidia Pharma USA INC. | $19.79 | 2022 | |
| Medtronic, INC. | $18.88 | 2023 | Venaseal |
| Genentech USA, INC. | $15.81 | 2020 | |
| Theratechnologies INC. | $13.09 | 2024 | Egrifta, Trogarzo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.84 | 2019 | |
| Daiichi Sankyo INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Solinas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.